Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Effect of Vaccination against COVID-19 in Cancer Patients: Final Results of the COICA Trial.
Di Lorenzo G, Ingenito C, D'Ambrosio B, Ranieri C, Iuliucci MR, Iervolino M, Primiano F, Buonerba L, Busto G, Ferrara C, Libroia A, Ragone G, De Falco F, Costabile F, Fimiani P, Ugliano F, Leo E, Roviello G, Scafuri L, Buonerba C. Di Lorenzo G, et al. Among authors: scafuri l. Oncology. 2022;100(9):512-518. doi: 10.1159/000525962. Epub 2022 Jul 11. Oncology. 2022. PMID: 35817009 Free article.
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-Line Sunitinib (QUASAR): Results of a Phase I Trial.
Buonerba C, De Placido P, Bruzzese D, Pagliuca M, Ungaro P, Bosso D, Ribera D, Iaccarino S, Scafuri L, Liotti A, Romeo V, Izzo M, Perri F, Casale B, Grimaldi G, Vitrone F, Brunetti A, Terracciano D, Marinelli A, De Placido S, Di Lorenzo G. Buonerba C, et al. Among authors: scafuri l. Front Pharmacol. 2018 Mar 16;9:189. doi: 10.3389/fphar.2018.00189. eCollection 2018. Front Pharmacol. 2018. PMID: 29615901 Free PMC article.
Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis.
Buonerba C, Iaccarino S, Dolce P, Pagliuca M, Izzo M, Scafuri L, Costabile F, Riccio V, Ribera D, Mucci B, Carrano S, Picozzi F, Bosso D, Formisano L, Bianco R, De Placido S, Di Lorenzo G. Buonerba C, et al. Among authors: scafuri l. Cancers (Basel). 2019 Aug 28;11(9):1259. doi: 10.3390/cancers11091259. Cancers (Basel). 2019. PMID: 31466227 Free PMC article. Review.
Outcomes Associated with First-Line anti-PD-1/ PD-L1 agents vs. Sunitinib in Patients with Sarcomatoid Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Buonerba C, Dolce P, Iaccarino S, Scafuri L, Verde A, Costabile F, Pagliuca M, Morra R, Riccio V, Ribera D, De Placido P, Romeo V, Crocetto F, Longo N, Imbimbo C, De Placido S, Di Lorenzo G. Buonerba C, et al. Among authors: scafuri l. Cancers (Basel). 2020 Feb 10;12(2):408. doi: 10.3390/cancers12020408. Cancers (Basel). 2020. PMID: 32050629 Free PMC article. Review.
Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis.
Buonerba C, Ferro M, Dolce P, Crocetto F, Verde A, Lucarelli G, Scafuri L, Facchini S, Vaia A, Marinelli A, Terracciano D, Montella L, Longo N, Imbimbo C, Mirone V, Di Lorenzo G, De Placido S, Sonpavde G. Buonerba C, et al. Among authors: scafuri l. Crit Rev Oncol Hematol. 2020 Jul;151:102992. doi: 10.1016/j.critrevonc.2020.102992. Epub 2020 May 23. Crit Rev Oncol Hematol. 2020. PMID: 32474391
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings.
Ferro M, Lucarelli G, Crocetto F, Dolce P, Verde A, La Civita E, Zappavigna S, de Cobelli O, Di Lorenzo G, Facchini BA, Scafuri L, Onofrio L, Porreca A, Busetto GM, Sonpavde G, Caraglia M, Klain M, Terracciano D, De Placido S, Buonerba C. Ferro M, et al. Among authors: scafuri l. Crit Rev Oncol Hematol. 2021 Jan;157:103198. doi: 10.1016/j.critrevonc.2020.103198. Epub 2020 Dec 13. Crit Rev Oncol Hematol. 2021. PMID: 33316417
Assessment of Total, PTEN-, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide.
Di Lorenzo G, Zappavigna S, Crocetto F, Giuliano M, Ribera D, Morra R, Scafuri L, Verde A, Bruzzese D, Iaccarino S, Costabile F, Onofrio L, Viggiani M, Palmieri A, De Placido P, Marretta AL, Pietroluongo E, Luce A, Abate M, Navaeiseddighi Z, Caputo VF, Celentano G, Longo N, Ferro M, Morelli F, Facchini G, Caraglia M, De Placido S, Buonerba C. Di Lorenzo G, et al. Among authors: scafuri l. Clin Genitourin Cancer. 2021 Oct;19(5):e286-e298. doi: 10.1016/j.clgc.2021.03.021. Epub 2021 Apr 3. Clin Genitourin Cancer. 2021. PMID: 33958297
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis.
Ferro M, de Cobelli O, Musi G, Lucarelli G, Terracciano D, Pacella D, Muto T, Porreca A, Busetto GM, Del Giudice F, Soria F, Gontero P, Cantiello F, Damiano R, Crocerossa F, Farhan ARA, Autorino R, Vartolomei MD, Muto M, Marchioni M, Mari A, Scafuri L, Minervini A, Longo N, Chiancone F, Perdona S, De Placido P, Verde A, Catellani M, Luzzago S, Mistretta FA, Ditonno P, Caputo VF, Battaglia M, Zamboni S, Antonelli A, Greco F, Russo GI, Hurle R, Crisan N, Manfredi M, Porpiglia F, Di Lorenzo G, Crocetto F, Buonerba C. Ferro M, et al. Among authors: scafuri l. Front Oncol. 2021 May 11;11:651745. doi: 10.3389/fonc.2021.651745. eCollection 2021. Front Oncol. 2021. PMID: 34046347 Free PMC article.
Immune checkpoint inhibitors in penile cancer.
Buonerba C, Scafuri L, Costabile F, D'Ambrosio B, Gatani S, Verolino P, Trolio RD, Cosimato V, Verde A, Lorenzo GD. Buonerba C, et al. Among authors: scafuri l. Future Sci OA. 2021 May 21;7(7):FSO714. doi: 10.2144/fsoa-2021-0044. eCollection 2021 Aug. Future Sci OA. 2021. PMID: 34258024 Free PMC article. No abstract available.
32 results